Growing at a CAGR of 6.9% between 2024 and 2030, the intubation tubes market value is expected to reach USD 4,294.4 million by 2030. This is attributed to the rapid surge in cancer burden, significant incidence of maxillofacial trauma, thus resulting in a spike in the volume of facial surgeries; and development of advanced intubation tubes.
There has been a rapid surge in the number of cancer cases and related deaths around the world. According to the NIH, the number of cancer cases in the U.S. is believed to surge to 29.5 million each year and related deaths to 16.4 million by 2040. People diagnosed with malignant tumors are often in need of surgical procedures. Tracheal intubation becomes crucial for patients undergoing surgery under general anesthesia, as well as patients who are severely ill and admitted to the intensive care unit (ICU) or emergency room (ER). Moreover, a variety of intubation devices are needed for patients who are suffering from tumors in the head and neck region or in cases where patients have difficult airways.
Another factor contributing to the market growth is the rising inclination of individuals toward undergoing surgery for maxillofacial trauma (MFT), as it has become one of the most-significant health hazards. It not only results in facial deformity and complete or partial loss of chewing function but also has a significant emotional and social impact on an individual, such as low self-esteem, stress, and feeling of social marginalization.
Additionally, MFT has become a serious burden for the ER department due to a rise in the number of accidents in different fields and activities, such as workplaces, homes, sports, and accidents involving bicycles and motor vehicles. In addition, physical aggression and recklessness during driving, such as driving in a state of drunkenness and improper or lack of usage of helmets on two wheelers, are increasing the cases of MFT, which, in turn, is increasing the volume of intubations.
Moreover, the significant advancements in the field of healthcare technology have led to a rapid surge in the development of better intubation devices, which have also proved to be safer and more effective than the traditional ones. Additionally, they protect patients from hospital-acquired infections, which prominently occur with the usage of traditional intubation tubes, because of the presence of antimicrobial coatings over them.
On the basis of end user, the hospitals category leads the market, with a share of 45% in 2023. This is attributed to the rising number of hospitalizations around the world as people are becoming increasingly aware of proper disease treatment. Moreover, the number of patient admissions is surging in hospitals due to the increasing demand for surgical procedures, as a large number of people are suffering from critical illnesses or chronic ailments. Additionally, patients prefer hospitals due to the presence of highly skilled medical practitioners and nursing staff.
The clinics category is expected to witness fast growth during the forecast period. This is because of the growing prevalence of chronic ailments and the increasing awareness among patients regarding the benefits of clinics, including affordable services and immediate assistance.
Ambulatory surgical centers are expected to witness significant growth as well. This is credited to the advantages offered by these medical institutions, such as economical services, as the surgical procedures are performed on an outpatient basis. This eliminates the need for an overnight stay, thereby resulting in a considerable cost reduction. Furthermore, due to the presence of fewer patients here in comparison to hospitals, the chances of contracting infections are much lower. The presence of a wide range of specialized services at these institutions is an added advantage contributing to the category’s growth.
Asia-Pacific is expected to witness the fastest growth during the projection period. This is credited to the rising pollution levels resulting in respiratory conditions, growing geriatric population, and significant prevalence of cardiopulmonary ailments, all of which ultimately lead to the rising need for surgeries.
Moreover, the increasing investments in the setup and advancement of healthcare facilities and the growing awareness among people regarding early disease diagnosis and treatment are propelling the growth of the regional market.
Key players in the market are Teleflex Incorporated, Medtronic plc, Medline Industries LP, Venner Medical International, Armstrong Medical Inc., ICU Medical Inc., and Convatec Limited.